Title

Aromatherapy as an adjunctive therapy for neonatal abstinence syndrome: A pilot study.

Document Type

Article

Publication Date

3-2020

Identifier

DOI: 10.5055/jom.2020.0558

Abstract

OBJECTIVE: To determine if aromatherapy added to the current standard of care for opioid withdrawal syndrome decreases hospitali-zation and need for opioid replacement in neonates.

DESIGN: Nonblinded, randomized control trial.

SETTING: Level 4 neonatal intensive care unit (NICU).

PATIENTS AND PARTICIPANTS: Thirty eight patients met inclusion criteria of greater than or equal to 36 weeks of gestation, history of in-trauterine opioid exposure, primary diagnosis of neonatal abstinence syndrome (NAS), and parental permission to participate.

INTERVENTIONS: Infants were randomized to either a standard therapy group or a standard therapy plus aromatherapy.

MAIN OUTCOME MEASURE(S): Duration of therapy and length of stay.

RESULTS: Our pilot study showed that the use of aromatherapy in conjunction with standard therapy reduced the duration of medica-tion treatment by 41 percent and hospital length of stay in the NICU by 36 percent.

CONCLUSIONS: The use of aromatherapy appears to help mitigate symptoms of NAS and offers to be a viable treatment modality when used with conventional therapy.

Journal Title

J Opioid Manag

Volume

16

Issue

2

First Page

119

Last Page

125

Share

COinS